bioAffinity Technologies Publishes Sputum Processing and Innovative High-Throughput Analysis Methods
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held company focused on early diagnostics and cancer therapeutics, announced publication in the peer-reviewed Journal of Visualized ...
In a meta-analysis, researchers found that sputum was more accurate than nasopharyngeal or oropharyngeal swabs. The study also shows early testing increased rates of COVID-19 diagnosis. Early and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback